About: Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebmed/2006/volume_11/issue_6/w
Subject	Drugs: cardiovascular system Menopause (including HRT) Musculoskeletal syndromes Injury Geriatric medicine Stroke breast neoplasms coronary disease Ischaemic heart disease Osteoporosis raloxifene selective oestrogen receptor modulators Pancreas and biliary tract Therapeutics Clinical trials (epidemiology)
Title	Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebmed/2006/volume_11/issue_6/B3555EDB3EEC38C5E053120B220A16A6/m/print http://hub.abes.fr/bmj/periodical/ebmed/2006/volume_11/issue_6/B3555EDB3EEC38C5E053120B220A16A6/m/web
related by	http://hub.abes.fr/bmj/periodical/ebmed/2006/volume_11/issue_6/B3555EDB3EEC38C5E053120B220A16A6/authorship/1
article type	research-article
is part of this journal	Evidence Based Medicine
PubMed ID	17213172

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata